The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson's disease

NeuroReport

Volumn 21, Issue 4, 2010, Pages 268-272

  Yang, Xinxin ^a   Song, Lu ^a   Liu, Zhenguo ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cyclooxygenase 2; Parkinson's disease; Repetitive transcranial magnetic stimulation; Tumor necrosis factor alpha

Indexed keywords

APOMORPHINE; CYCLOOXYGENASE 2; OXIDOPAMINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; THERAPY EFFECT; TISSUE LEVEL; TRANSCRANIAL MAGNETIC STIMULATION;

ANIMALS; CHROMATOGRAPHY, LIQUID; CORPUS STRIATUM; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE ANTAGONISTS; FEMALE; MICROINJECTIONS; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TRANSCRANIAL MAGNETIC STIMULATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76849096611     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328335b411     Document Type: Article

References (21)

1. Sherer TB, Betarbet R, Greenamyre JT. Pathogenesis of Parkinson's disease. Curr Opin Investig Drugs 2001; 2:657-662.
2. Lang AE, Obeso JA. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004; 3:309-316.
3. Park JA, Kim S, Lee SY, Kim CS, Kim Do K, Kim SJ, et al.. Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death. Neuroreport 2008; 19:1301-1304.
4. Hernan MA, Logroscino G, Garcia Rodriguez LA. Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology 2006; 66:1097-1099.
5. Bartels AL, Leenders KL. Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET. Mov Disord 2007; 22:1852-1856.
6. Dheen ST, Kaur C, Ling EA. Microglial activation and its implications in the brain diseases. Curr Med Chem 2007; 14:1189-1197.
7. Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, et al.. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J Neurochem 2007; 100:1375-1386.
8. Asanuma M, Miyazaki I. Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's disease. Curr Pharm Des 2008; 14:1428-1434.
9. Barker AT, Jalinous R, Freeton H, Jarratt JA. Motor responses to noninvasive brain stimulation in clinical practice. Electroenceph Clin Neurophysiol 1985; 61:570-574.
10. Fregni F, Pascual-Leone A. Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. Nat Clin Pract Neurol 2007; 3:383-393.
11. Cattaneo Z, Silvanto J. Investigating visual motion perception using the transcranial magnetic stimulation-adaptation paradigm. Neuroreport 2008; 19:1423-1427.
12. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic Press; 1998.
13. Yang J, Hu LF, Liu X, Zhou F, Ding JH, Hu G. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study. Life Sci 2006; 78:1940-1944.
14. De Meira Santos Lima M, Braga Reksidler A, Marques Zanata S, Bueno Machado H, Tufik S, Vital MA. Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats. Brain Res 2006; 1101:117-125.
15. Ebert U, Ziemann U. Altered seizure susceptibility after high-frequency transcranial magnetic stimulation in rats. Neurosci Lett 1999; 273:155-158. (Pubitemid 29430173)
16. O'Banion MK. COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration. Expert Opin Investig Drugs 1999; 8:1521-1536.
17. Kuwano T, Nakao S, Yamamoto H, Tsuneyoshi M, Yamamoto T, Kuwano M, et al.. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J 2004; 18:300-310.
18. Wang T, Pei Z, ZhangW, Liu B, Langenbach R, Lee C, et al.. MPP+ -induced COX-2 activation and subsequent dopaminergic neurodegeneration. FASEB J 2005; 19:1134-1136.
19. Liang X,Wu L,Wang Q, Hand T, Bilak M, McCullough L, et al.. Function of COX-2 and prostaglandins in neurological disease. J Mol Neurosci 2007; 33:94-99.
20. Wahner AD, Bronstein JM, Bordelon YM, Ritz B. Nonsteroidal antiinflammatory drugs may protect against Parkinson disease. Neurology 2007; 69:1836-1842.
21. Kanno M, Matsumoto M, Togashi H, Yoshioka M, Mano Y. Effects of acute repetitive transcranial magnetic stimulation on dopamine release in the rat dorsolateral striatum. J Neurol Sci 2004; 217:73-81.